Offer - Urjas Oil for just ₹ 1 X
StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop is an allopathic medicine The correct dosage of StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop safe for pregnant women?
It is not known what effect StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop will have on pregnant women, because no research work has been carried out on this till date.
Is the use of StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop safe during breastfeeding?
There is no research available on the side effects of StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop in breastfeeding women. Therefore, its impact is unknown.
What is the effect of StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop on the Kidneys?
StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop is completely safe for kidneys.
What is the effect of StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop on the Liver?
Using StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop does not have any harmful effects on the liver.
What is the effect of StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop on the Heart?
There are no any side effects of StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop for the heart.
StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop unless your doctor advises you to do so -
Is this StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop habit forming or addictive?
No, you will not get addicted to StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop can make you feel drowsy.
Is it safe?
StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop in mental disorders is not effective.
Interaction between Food and StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop
Taking StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop with food is safe.
Interaction between Alcohol and StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking StayHappi Moxifloxacin Hydrochloride + Lotepretnol Eye Drop.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lotemax® (loteprednol etabonate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1402
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avelox (moxifloxacin hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. Davis’s Drug Guide For Nurses. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1402.
Highlights Of Prescribing Information [Internet]: VIGAMOX® (moxifloxacin hydrochloride ophthalmic solution) 0.5% as base Sterile topical ophthalmic solution. USFDA
Product Description [Internet]: LOTEMAX. Bausch & Lomb